Literature DB >> 20609743

Comparison of Norwood shunt types: do the outcomes differ 6 years later?

Eric M Graham1, Sinai C Zyblewski, Jacob W Phillips, Girish S Shirali, Scott M Bradley, Geoffery A Forbus, Varsha M Bandisode, Andrew M Atz.   

Abstract

BACKGROUND: A modification to the Norwood procedure involving a right ventricle-to-pulmonary artery (RV-PA) shunt may improve early postoperative outcomes. Concerns remain about the effect of the right ventriculotomy required with this shunt on long-term ventricular function.
METHODS: Between January 2000 and April 2005, 76 patients underwent the Norwood procedure, 35 with a modified Blalock-Taussig shunt (mBTS) and 41 with a RV-PA shunt. Patients were monitored until death or September 1, 2009, with an average follow-up of 6.8 years. Cardiac catheterization, echocardiograms, perioperative Fontan courses, and need for cardiac transplantation were compared between groups.
RESULTS: Cumulative survival was 63% (22 of 35) in the mBTS group vs 78% (32 of 41) in the RV-PA group (p = 0.14). Pre-Fontan echocardiography revealed poorer ventricular function in RV-PA patients (p = 0.03). Cardiac transplantation was required in 6 of 32 (19%) patients with a prior RV-PA shunt vs 1 of 23 (4%) in the mBTS group (p = 0.06). This results in an almost identical cumulative transplant-free survival between groups; 60% (21 of 35) in the mBTS group and 63% (26 of 41) in the RV-PA group (p = 0.95).
CONCLUSIONS: Neither shunt offers a clear survival advantage through an average follow-up of 6.8 years. The RV-PA shunt results in impaired late ventricular function that may result in an increased need for cardiac transplantation. Copyright 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20609743     DOI: 10.1016/j.athoracsur.2010.03.078

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  12 in total

1.  Preoperative cerebral hemodynamics from birth to surgery in neonates with critical congenital heart disease.

Authors:  Jennifer M Lynch; Tiffany Ko; David R Busch; John J Newland; Madeline E Winters; Kobina Mensah-Brown; Timothy W Boorady; Rui Xiao; Susan C Nicolson; Lisa M Montenegro; J William Gaynor; Thomas L Spray; Arjun G Yodh; Maryam Y Naim; Daniel J Licht
Journal:  J Thorac Cardiovasc Surg       Date:  2018-05-03       Impact factor: 5.209

2.  Fate of ventricular and valve performance following early bidirectional Glenn procedure after Norwood operation controlled for hypoplastic left heart syndome anatomic subtype.

Authors:  Anastasios C Polimenakos; John W Bokowski; Hani S Ghawi; Chawki F El-Zein; Michel N Ilbawi
Journal:  Pediatr Cardiol       Date:  2013-10-15       Impact factor: 1.655

Review 3.  Improvements in survival and neurodevelopmental outcomes in surgical treatment of hypoplastic left heart syndrome: a meta-analytic review.

Authors:  Joseph J Sistino; Heather Shaw Bonilha
Journal:  J Extra Corpor Technol       Date:  2012-12

4.  Hypoplastic left heart syndrome and aortic atresia-mitral stenosis variant: role of myocardial protection strategy and impact of ventriculo-coronary connections after stage I palliation.

Authors:  Anastasios C Polimenakos; Shyam K Sathanandam; Tarek S Husayni; Chawki F El Zein; David A Roberson; Michel N Ilbawi
Journal:  Pediatr Cardiol       Date:  2011-06-05       Impact factor: 1.655

5.  Risk factors for failed staged palliation after bidirectional Glenn in infants who have undergone stage one palliation.

Authors:  Kevin G Friedman; Joshua W Salvin; David Wypij; Yared Gurmu; Emile A Bacha; David W Brown; Peter C Laussen; Mark A Scheurer
Journal:  Eur J Cardiothorac Surg       Date:  2011-03-05       Impact factor: 4.191

6.  Impact of initial shunt type on cardiac size and function in children with single right ventricle anomalies before the Fontan procedure: the single ventricle reconstruction extension trial.

Authors:  Peter C Frommelt; Eric Gerstenberger; James F Cnota; Meryl S Cohen; Jessica Gorentz; Kevin D Hill; J Blaine John; Jami C Levine; Jimmy Lu; William T Mahle; Rachel T McCandless; Luc Mertens; Gail D Pearson; Carolyn Spencer; Deepika Thacker; Ismee A Williams; Pierre C Wong; Jane W Newburger
Journal:  J Am Coll Cardiol       Date:  2014-11-03       Impact factor: 24.094

7.  Impact of Initial Shunt Type on Echocardiographic Indices in Children After Single Right Ventricle Palliations.

Authors:  Peter C Frommelt; Chenwei Hu; Felicia Trachtenberg; Jeanne Marie Baffa; Richard J Boruta; Shahryar Chowdhury; James F Cnota; Andreea Dragulescu; Jami C Levine; Jimmy Lu; Laura Mercer-Rosa; Thomas A Miller; Amee Shah; Timothy C Slesnick; Gary Stapleton; Jessica Stelter; Pierre Wong; Jane W Newburger
Journal:  Circ Cardiovasc Imaging       Date:  2019-02       Impact factor: 7.792

8.  Impact of initial norwood shunt type on right ventricular deformation: the single ventricle reconstruction trial.

Authors:  Garick D Hill; Peter C Frommelt; Jessica Stelter; M Jay Campbell; Meryl S Cohen; Rami Kharouf; Wyman W Lai; Jami C Levine; Jimmy C Lu; Shaji C Menon; Timothy C Slesnick; Pierre C Wong; David E Saudek
Journal:  J Am Soc Echocardiogr       Date:  2015-02-15       Impact factor: 5.251

9.  Continuous cerebral hemodynamic measurement during deep hypothermic circulatory arrest.

Authors:  David R Busch; Craig G Rusin; Wanda Miller-Hance; Kathy Kibler; Wesley B Baker; Jeffrey S Heinle; Charles D Fraser; Arjun G Yodh; Daniel J Licht; Kenneth M Brady
Journal:  Biomed Opt Express       Date:  2016-08-15       Impact factor: 3.732

10.  Time to surgery and preoperative cerebral hemodynamics predict postoperative white matter injury in neonates with hypoplastic left heart syndrome.

Authors:  Jennifer M Lynch; Erin M Buckley; Peter J Schwab; Ann L McCarthy; Madeline E Winters; David R Busch; Rui Xiao; Donna A Goff; Susan C Nicolson; Lisa M Montenegro; Stephanie Fuller; J William Gaynor; Thomas L Spray; Arjun G Yodh; Maryam Y Naim; Daniel J Licht
Journal:  J Thorac Cardiovasc Surg       Date:  2014-06-27       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.